Literature DB >> 18457959

Incidence, associated factors and evolution of non-severe functional mitral regurgitation in patients with severe aortic stenosis undergoing aortic valve replacement.

Juan Caballero-Borrego1, Juan José Gómez-Doblas, Fernando Cabrera-Bueno, José Manuel García-Pinilla, José María Melero, Carlos Porras, Eduardo Olalla, Eduardo De Teresa Galván.   

Abstract

INTRODUCTION: In order to improve the prognosis, repair of severe mitral regurgitation should be undertaken at the same time as aortic valve replacement in patients with severe aortic valve stenosis. However, mitral regurgitation may be secondary to pressure overload or ventricular dysfunction and improve after surgery. AIM: To assess the incidence of non-severe functional mitral regurgitation before and after isolated aortic valve replacement and determine its influence on the postoperative course.
METHODS: The clinical and surgical characteristics were compared in a cohort of 577 consecutive patients who underwent isolated aortic valve replacement.
RESULTS: The mean age was 68.4+/-9.2 years (44% women). Non-severe functional mitral valve regurgitation was detected prior to surgery in 26.5% of the patients. These patients were older (p=0.009), more often had ventricular dysfunction (p=0.005) and pulmonary hypertension (0.002), and had been admitted more frequently for heart failure (0.002), with fewer of them conserving sinus rhythm (p<0.001). Additionally, the pre-surgery existence of mitral regurgitation was associated with greater morbidity and mortality (10.5% vs 5.6%; p=0.025). The mitral regurgitation disappeared or improved prior to hospital discharge in 56.2% and 15.6%, respectively. Independent factors predicting this improvement were the presence of coronary lesions (OR 3.7, p=0.038), and the absence of diabetes (OR 0.28, p=0.011) and pulmonary hypertension (0.33, p=0.046).
CONCLUSIONS: The presence of intermediate degree mitral regurgitation in patients undergoing isolated aortic valve replacement increases morbidity and mortality. However, a high percentage of those who do survive experience disappearance or improvement of the mitral regurgitation.

Entities:  

Mesh:

Year:  2008        PMID: 18457959     DOI: 10.1016/j.ejcts.2008.03.055

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  10 in total

1.  Evaluation of mitral regurgitation by an integrated 2D echocardiographic approach in patients undergoing transcatheter aortic valve replacement.

Authors:  R Jansen; A M Wind; M J Cramer; F Nijhoff; P Agostoni; F Z Ramjankhan; W J Suyker; P R Stella; S A J Chamuleau
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-10       Impact factor: 2.357

2.  Primary Mitral Valve Regurgitation Outcome in Patients With Severe Aortic Stenosis 1 Year After Transcatheter Aortic Valve Implantation: Echocardiographic Evaluation.

Authors:  Thiago Marinho Florentino; David Le Bihan; Alexandre Antonio Cunha Abizaid; Alexandre Vianna Cedro; Amably Pessoa Corrêa; Alexandre Roginski Mendes Dos Santos; Alexandre Costa Souza; Tiago Costa Bignoto; José Eduardo Moraes Rego Sousa; Amanda Guerra de Moraes Rego Sousa
Journal:  Arq Bras Cardiol       Date:  2017-07-10       Impact factor: 2.000

3.  Quantitative evaluation of change in coexistent mitral regurgitation after aortic valve replacement.

Authors:  David J Kaczorowski; John W Macarthur; Jessica Howard; Dale Kobrin; Alex Fairman; Y Joseph Woo
Journal:  J Thorac Cardiovasc Surg       Date:  2012-12-11       Impact factor: 5.209

4.  Transseptal mitral valve replacement after transcatheter aortic valve implantation.

Authors:  Laura D Flannery; Robert C Lowery; Xiumei Sun; Lowell Satler; Paul Corso; Augusto Pichard; Zuyue Wang
Journal:  Tex Heart Inst J       Date:  2012

5.  Concomitant Mitral Regurgitation in Patients Undergoing Surgical Aortic Valve Replacement for Aortic Stenosis: A Systematic Review.

Authors:  Francis P Cheung; Cheng He; Philippa R Eaton; Jim Dimitriou; Andrew E Newcomb
Journal:  Ann Thorac Cardiovasc Surg       Date:  2022-02-09       Impact factor: 1.889

6.  The beneficial effects of TAVI in mitral insufficiency.

Authors:  Marco Fabio Costantino; Ernesta Dores; Pasquale Innelli; Antonella Matera; Vincenza Santillo; Roberto Violini; Rosario Fiorilli; GianGiuseppe Cappabianca; Nicola Marraudino; Eugenio Picano; Giandomenico Tarsia
Journal:  Cardiovasc Ultrasound       Date:  2015-12-30       Impact factor: 2.062

7.  [Results of aortic valve replacement in patients with aortic stenosis associated with severe left ventricular dysfunction].

Authors:  Abderrahmane Bakkali; Imad Jaabari; Claude Koulekey Dadji; Rochde Sayah; Mohamed Laaroussi
Journal:  Pan Afr Med J       Date:  2018-01-26

8.  Is isolated aortic valve replacement sufficient to treat concomitant moderate functional mitral regurgitation? A propensity-matched analysis.

Authors:  Robert A Sorabella; Anna Olds; Halit Yerebakan; Dua Hassan; Michael A Borger; Michael Argenziano; Craig R Smith; Isaac George
Journal:  J Cardiothorac Surg       Date:  2018-06-19       Impact factor: 1.637

9.  Impact of Mitral Surgery for Mitral Regurgitation on Coexisting Aortic Regurgitation.

Authors:  Kohei Hachiro; Takeshi Kinoshita; Tohru Asai; Tomoaki Suzuki
Journal:  Ann Thorac Cardiovasc Surg       Date:  2019-08-07       Impact factor: 1.520

Review 10.  The Prospects of Secondary Moderate Mitral Regurgitation after Aortic Valve Replacement -Meta-Analysis.

Authors:  Ilija Bilbija; Milos Matkovic; Marko Cubrilo; Nemanja Aleksic; Jelena Milin Lazovic; Jelena Cumic; Vladimir Tutus; Marko Jovanovic; Svetozar Putnik
Journal:  Int J Environ Res Public Health       Date:  2020-10-08       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.